>>13500779
I'm not entirely certain this is true.
In a free market system, in theory, the person who develops the cure gets the most business. Again, in theory, as the means and access to biotech grow, the ability for new market competitors should also expand - meaning that any conspiracy to hide cures among the mega-corporations have a shelf-life. While I will agree that a savvy corporation would not likely market a cure when they can market a treatment, this benefit lasts only so long as there is no reason for their competitors or upstarts to upset the market with a cure.
After all, if you can get treated or cured - which would you pay for?
Thus, I ask why it is medical competition does not release cures more frequently - and I believe there are two substantial factors. First is the FDA regulations. Because a business must front the costs to get a drug treatment through FDA inspection, there is a significant barrier to entry into the market.
Second is the nature of market patents. The only drug a company is going to sink time and money into clearing regulatory systems is a drug they can hold the exclusive rights to. This means that there is almost no incentive to use "multi-purpose" drugs for treatment. Because of how FDA rules work, even if a drug is very well studied with known toxicity, side effects, etc - a doctor cannot prescribe the medication for any diagnosed symptom or illness it has not already been approved for by the FDA. So, if a simple cough syrup could cure cancer, or something, but that syrup has no ability to be patented, the companies will not invest money into clearing regulatory hurdles to authorize it as a cancer treatment.
They will go out of their way to develop a whole new synthetic drug that does the exact same thing as some over the counter medicine - just to patent it and push it through as a treatment.
I am exaggerating to some degree, but the trials to clear a drug through the FdA are not cheap and rather than the market working to bring an effective product to the consumer at a reasonable price, the market works to develop an exclusive legal right to deny its production competitors access to the same market - because if I were to get aspirin approved as a cancer treatment at great cost to myself, then ANY aspirin from any manufacturer can be prescribed to a patient.
But if the drug that undergoes approval is a special one that I hold the patent to - then I can recover the costs of all development and approval. …. And possibly completely gouge the market.
Another aspect is that share holders of a company can never agree on much other than mutual profit for themselves. This will invariably create a corporate climate which, to get advanced, one creates profit at any expense to the business. Wages get frozen to fuel profit reports, workplace quality gets sacrificed, labor is exported. You even get such insane decisions as choosing to relocate manufacturing to the very countries executing industrial espionage and hosting state-sponsored competitors to their market.
If it gets a profit, it means more cocaine and more hookers. It is the common denominator among corporate share holders and every large corporation will inevitably be hollowed out by its owners when said owners can't actually own the business as an expression of their self.
Something to think about in the context of a democratic republic.